BZ:
705,
717,
736
Smythies, JR; Levy, CK. The comparative psychopharmacology of some mescaline analogues. Br. J. Psychiatry, 1 Jan 1960, 106 (443), 531–536. 637 kB. https://doi.org/10.1192/bjp.106.443.531 #V
Nichols, DE; Dyer, DC. Lipophilicity and serotonin agonist activity in a series of 4-substituted mescaline analogues. J. Med. Chem., 1 Feb 1977, 20 (2), 299–301. 409 kB. https://doi.org/10.1021/jm00212a022 #3e
Nichols, DE; Shulgin, AT; Dyer, DC. Directional lipophilic character in a series of psychotomimetic phenethylamine derivatives. Life Sci., 15 Aug 1977, 21 (4), 569–576. 320 kB. https://doi.org/10.1016/0024-3205(77)90099-6 #17
Kier, LB; Glennon, RA. Psychotomimetic phenalkylamines as serotonin agonists: An SAR analysis. Life Sci., 8 May 1978, 22 (18), 1589–1593. 238 kB. https://doi.org/10.1016/0024-3205(78)90053-X #17
Hyperlab. Hyperlab new compounds. 29 Sep 2014. 232 kB. Note: Contains links to hyperlab.info that require elevated access/karma to follow.
Kolaczynska, KE; Luethi, D; Trachsel, D; Hoener, MC; Liechti, ME. Receptor interaction profiles of 4-alkoxy-3,5-dimethoxy-phenethylamines (mescaline derivatives) and related amphetamines. Front. Pharmacol., 9 Feb 2022, 12 794254. 1.0 MB. https://doi.org/10.3389/fphar.2021.794254 #33
Gupta, SP; Singh, P; Bindal, MC. QSAR studies on hallucinogens. Chem. Rev., 1 Dec 1983, 83 (6), 633–649. 2.8 MB. https://doi.org/10.1021/cr00058a003 #74
25H-NBOH · 2C-H-NBOH · N-(2-Hydroxybenzyl)-2,5-dimethoxyphenethylamine
24H-NBOH · N-(2-Hydroxybenzyl)-2,4-dimethoxyphenethylamine
2,5-Dimethoxy-4-(2-methoxyphenyl)phenethylamine · 2C-BI-2
2,5-Dimethoxy-4-(3-methoxyphenyl)phenethylamine · 2C-BI-6
2,5-Dimethoxy-4-(4-methoxyphenyl)phenethylamine · 2C-BI-8
N-(4-Hydroxypheethyl)-β,4-dihydroxyamphetamine · N-4HOPhEt-β,4-DHA · Ritodrine
3,4-DHA-NBOMe · N-(2-Methoxybenzyl)-3,4-dihydroxyamphetamine